Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


KAGOOrouter不能用了-快连加速器app

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

KAGOOrouter不能用了-快连加速器app

KAGOOrouter不能用了-快连加速器app

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

KAGOOrouter不能用了-快连加速器app

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
闪飞 1  v2ray机场  miaoss秒速·加速器  悠悠加速器  手机下载器除了迅雷还有啥  赛 风 安卓版 apk  técnicas  顺丰游戏加速器翻墙